Forge Genetics, a biotechnology company at the forefront of gene-editing technology, has announced that Barnaby Kent MBA has been appointed to the Forge Genetics Advisory Board.
Barnaby has over 25 years of experience across technology and M&A leadership roles. He was previously CEO at Plumtree Group and was COO at LSE:AIM listed Ideagen for over a decade before their acquisition in 2022 for £1 billion.
Forge Genetics is a biotechnology start-up focused on revolutionising the gene-editing landscape to simplify precision genetics with its proprietary technology, Forge Editing. Barnaby’s role on the advisory board will leverage his knowledge in scaling and leadership, providing Forge Genetics with invaluable guidance and insight for strategic development.
“Barnaby asks questions that so quickly get to the crux of the problem or opportunity and is immensely useful in clarifying my thinking on how to scale Forge Genetics” - Dr Craig Woods, CEO
Barnaby Kent MBA holds a BSc (Hons) from the University of Southampton, and an MBA from Edinburgh Business School.